GlaxoSmithKline: all 4,196 studies
Page 39 of 42. Open to participants first (141), then studies with results posted, then the rest; newest registration first within each.
- SB-681323 In Subjects With Rheumatoid ArthritisCompletedNCT00320450Phase 2
- Topotecan Plus Cisplatin Versus Etoposide Plus Cisplatin In 1st Line Extensive Disease Small Cell Lung CancerCompletedNCT00320359Phase 3
- Comparison of Abacavir Following Once-Daily And Twice-Daily Administration In HIV Infected SubjectsCompletedNCT00320307Phase 1
- A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic RegimenWithdrawnNCT00319332Phase 3
- An Adaptive Design Trial Of GW274150 In The Treatment Of Acute MigraineCompletedNCT00319137Phase 2
- Social Anxiety Disorder Study Of ParoxetineCompletedNCT00318669Phase 3
- The Effect Of AVANDIA On The Late Asthmatic ResponseCompletedNCT00318630Phase 1
- Effect Of GW501516X On How The Heart Obtains And Uses EnergyTerminatedNCT00318617
- Safety Study of an Adjuvanted Candidate Influenza Vaccine to Prevent Influenza Disease in the Elderly PopulationCompletedNCT00318058Phase 1
- Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedNCT00317187Phase 3
- A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.CompletedNCT00317174Phase 2
- Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.CompletedNCT00317161Phase 3
- Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedNCT00317135Phase 3
- Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at BirthCompletedNCT00317122Phase 3
- Observational AVODART (Dutasteride) Study In Benign Prostatic Hyperplasia Subjects - OASISCompletedNCT00316732
- Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.TerminatedNCT00316680Phase 3
- Sexual Functioning Study With AntidepressantsCompletedNCT00316160Phase 4
- Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination SchedulesCompletedNCT00316147Phase 3
- Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple MyelomaCompletedNCT00315757Phase 2
- Viapaed Study In Children And Adolescents With AsthmaCompletedNCT00315744Phase 4
- Open-Label Extension of the Phase III Study With Tramiprosate (3APS) in Patients With Mild to Moderate Alzheimer's DiseaseStatus unknownNCT00314912Phase 3
- RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of RopiniroleCompletedNCT00314860Phase 3
- Effects Of Nadroparin In Patients With Lung, Pancreas Or Prostate CancerCompletedNCT00312013Phase 3
- Study to Evaluate the Safety and Immunogenicity of Pandemic Monovalent (H5N1) Influenza Vaccines (Whole Virus Formulation) in Adults 18 and 60 Years of AgeCompletedNCT00309647Phase 1
- Study to Evaluate the Safety and Immunogenicity of a Pandemic Influenza Vaccine in Adults Aged Between 18 and 60 YearsCompletedNCT00309634Phase 1
- Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488CompletedNCT00307567Phase 2
- A Lot-to-lot Consistency (3 Lots of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine) & Non-inferiority StudyCompletedNCT00307554Phase 3
- Assess the Immunogenicity of GSK Biologicals' 10-valent Pneumococcal Conjugate VaccineCompletedNCT00307541Phase 3
- Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly PopulationCompletedNCT00307528Phase 2
- Double-blind Study of Safety and Immunogenicity of Two Candidate Malaria Vaccines in Gabonese ChildrenCompletedNCT00307021Phase 2
- Study to Evaluate the Response Rate to the Licensed Pneumovax 23™ in Elderly Population.CompletedNCT00307008Phase 2
- Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™CompletedNCT00306982
- Annual Study for Fluarix RegistrationCompletedNCT00306943Phase 3
- Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.CompletedNCT00306696Phase 4
- Effect Of Rosiglitazone On Carotid Intima Media Thickness In Patients With Insulin Resistance Syndrome And/Or Type 2 DiabetesCompletedNCT00306644Phase 4
- A Study to Evaluate the Immunogenicity and Safety of GSK Biologicals' HPV Vaccine in Healthy Women Aged 18-35 YearsCompletedNCT00306241Phase 3
- Effect Of Talnetant Versus Risperidone Versus Placebo On Psychotic Symptoms In Schizophrenic PatientsCompletedNCT00300963Phase 2
- Post-marketing Safety Study of GSK Biologicals' Boostrix® VaccineCompletedNCT00297856
- A Safety And Tolerability Study Of Valaciclovir Oral Suspension In Infants And ChildrenCompletedNCT00297206Phase 1
- Weight Loss In Obese Subjects Taking Either GW869682 Or Placebo 3 Times Per Day For 12 WeeksCompletedNCT00297180Phase 2
- Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected SubjectsTerminatedNCT00297076Phase 3
- BRL49653C In Type 2 Diabetes -Comparison Study With Pioglitazone And Placebo By Monotherapy-CompletedNCT00297063Phase 3
- Study Of Patients With Allergic Rhinitis And AsthmaCompletedNCT00296530Phase 4
- Evaluation of COPD (Chronic Obstructive Pulmonary Disease) to Longitudinally Identify Predictive Surrogate EndpointsCompletedNCT00292552
- Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to InfantsCompletedNCT00291967Phase 2
- HuMax-CD20 in Active Rheumatoid Arthritis, Phase I/IICompletedNCT00291928Phase 2
- A Pharmacokinetic Study Of SB-681323 In Subjects With Coronary Heart Disease Undergoing Percutaneous InterventionCompletedNCT00291902Phase 2
- Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.CompletedNCT00291889Phase 1
- Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination ProductCompletedNCT00291382Phase 4
- GSK189075, GW869682 Or Placebo In Type 2 Diabetic PatientsCompletedNCT00291356Phase 2
- Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy InfantsCompletedNCT00290303Phase 3
- Evaluate the Immunogenicity & Safety of GSK Biologicals' HPV Vaccine in Female Subjects Aged 10-14 YearsCompletedNCT00290277Phase 3
- Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib VaccineCompletedNCT00289796Phase 2
- Assess the Immunogenicity & Safety of 2 Doses of Oral Live Attenuated Human Rota(HRV)Vaccine in Healthy Infants in IndiaCompletedNCT00289172Phase 3
- Efficacy and Safety of Two Doses of Liarozole vs. Placebo for the Treatment of Lamellar IchthyosisCompletedNCT00282724Phase 2/3
- Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary InsomniaCompletedNCT00280436Phase 2
- Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary InsomniaCompletedNCT00280423Phase 2
- Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideCompletedNCT00279045Phase 3
- GW406381 In Patients With Peripheral Nerve InjuryCompletedNCT00279032Phase 1
- Safety Study Using GSK233705 And Tiotropium In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00279019Phase 1
- Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung CancerCompletedNCT00276276Phase 3
- An Evaluation Of Mepolizumab In Therapy Of Eosinophilic Oesophagitis In Adult PatientsCompletedNCT00274703Phase 2
- Post-Operative Nausea And Vomiting Study In Female PatientsCompletedNCT00274690Phase 2
- Depression And Bipolar DisorderCompletedNCT00274677Phase 3
- A Study Of A New Medicine (GW679769) For The Treatment Of Social Anxiety DisorderCompletedNCT00273039Phase 2
- Study In Asthma ControlTerminatedNCT00273026Phase 4
- Study With GW274150 In Patients With Mild AsthmaCompletedNCT00273013Phase 1
- Clinical Evaluation Of GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)CompletedNCT00269126Phase 3
- Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or InsulinCompletedNCT00269061Phase 1
- SB-480848 In Subjects With Coronary Heart DiseaseCompletedNCT00269048Phase 2
- SPECT Study With SB-773812 In Schizophrenic PatientsCompletedNCT00269035Phase 1
- Use Of SB-705498 In The Acute Treatment Of MigraineCompletedNCT00269022Phase 2
- Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00268216Phase 3
- Airway Inflammation In Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT00268177Phase 3
- Spanish Validation Of Quality of Life Questionnaire (QOLIE-10) For EpilepsyCompletedNCT00264680
- Study In Patients With DyslipidaemiaCompletedNCT00264667Phase 2
- Long-term Study Of Paroxetine in Women and MenCompletedNCT00264654Phase 3
- GW679769 In FibromyalgiaCompletedNCT00264628
- Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice VersaCompletedNCT00264615Phase 3
- Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and SafetyCompletedNCT00263692Phase 2
- Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine.CompletedNCT00263679Phase 3
- Safety, Reactogenicity & Immunogenicity Study to Evaluate a Booster Dose of GSK Biologicals' Hib-MenC Given With Priorix™ in Toddlers (13-14 m) Primed With 3 Doses of Hib and MenC-CRM197CompletedNCT00263653Phase 3
- Effects Of Lapatinib (GW572016) In Patients With Relapsed Adenocarcinoma Of The EsophagusCompletedNCT00259987Phase 2
- A Study To Determine If Two Different Versions Of Topotecan Have The Same Potency In Patients With Advanced Solid TumorsCompletedNCT00259935Phase 1
- Observational Study Of An Electronic Questionnaire In Patients With Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00259909
- In-patient Study in Patients With Type 2 Diabetes MellitusCompletedNCT00259896Phase 1
- Combination Of PAXIL Tablet And BenzodiazepinesCompletedNCT00259883Phase 4
- SB-773812 Administered In Adults With SchizophreniaCompletedNCT00259870Phase 2
- Primary & Booster Immunogenicity Study of GSK Biologicals' Hib-MenC Versus a Licensed Men-C VaccineCompletedNCT00258700Phase 3
- To Examine The Effects Of Lapatinib On Orally And Intravenously Administered Midazolam In Cancer PatientsCompletedNCT00258050Phase 1
- GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected AdultsCompletedNCT00257621Phase 2
- Perennial Allergic Rhinitis In Pediatric SubjectsCompletedNCT00257595Phase 3
- Study Of Cutaneous Disease Accompanied With Pruritus In PediatricsCompletedNCT00257582Phase 3
- Study Of Atopic Dermatitis In PediatricsCompletedNCT00257569Phase 3
- Single Dose Study Of GW856553 On A Protein That Is An Indicator For Rheumatoid Arthritis (RA)CompletedNCT00256919Phase 2
- Fibromyalgia Study In AdultsCompletedNCT00256893Phase 2
- Pazopanib (GW786034) In Subjects With Relapsed Or Refractory Multiple MyelomaCompletedNCT00256880Phase 2
- Study Of Perennial Allergic Rhinitis In PediatricsCompletedNCT00253058Phase 3
- Evaluation of Efficacy and Safety of Combined Omacor (Omega-3-acid Ethyl Esters) and Simvastatin Therapy in Hypertriglyceridemic SubjectsCompletedNCT00246701Phase 3
- Evaluation of Efficacy and Safety of Omacor (Omega-3-acid Ethyl Esters) as Add-on Therapy in Hypertriglyceridemic Subjects Treated With Antara (Fenofibrate) Followed by an 8-week ExtensionCompletedNCT00246636Phase 4